GenRx Perindopril Arginine/Amlodipine 5/5 perindopril arginine 5 mg and amlodipine (as besilate) 5 mg uncoated tablet bottle Australia - English - Department of Health (Therapeutic Goods Administration)

genrx perindopril arginine/amlodipine 5/5 perindopril arginine 5 mg and amlodipine (as besilate) 5 mg uncoated tablet bottle

arrotex pharmaceuticals pty ltd - amlodipine besilate, quantity: 6.94 mg (equivalent: amlodipine, qty 5 mg); perindopril arginine, quantity: 5 mg - tablet - excipient ingredients: microcrystalline cellulose; colloidal anhydrous silica; magnesium stearate; croscarmellose sodium - perindopril arginine and amlodipine combination tablet is indicated as substitution therapy for the treatment of hypertension and/or stable coronary heart disease in patients already controlled with separate doses of perindopril and amlodipine, given concurrently at the same dose level. treatment should not be initiated with this combination.

PRESTALIA- perindopril arginine, amlodipine besylate tablet United States - English - NLM (National Library of Medicine)

prestalia- perindopril arginine, amlodipine besylate tablet

marina biotech - perindopril arginine (unii: tft5im1kgb) (perindoprilat - unii:2uv6znq92k), amlodipine besylate (unii: 864v2q084h) (amlodipine - unii:1j444qc288) - perindopril arginine 3.5 mg - prestalia contains perindopril arginine, an angiotensin converting enzyme inhibitor, and amlodipine, a dihydropyridine calcium channel blocker, and is indicated for the treatment of hypertension, to lower blood pressure. prestalia may be used in patients whose blood pressure is not adequately controlled on monotherapy. prestalia may be used as initial therapy in patients likely to need multiple drugs to achieve blood pressure goals. lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. these benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes, including amlodipine and the ace inhibitor class to which perindopril principally belongs. there are no controlled trials demonstrating risk reduction with prestalia. control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithr